Silver Book Fact

Between 1998 and 2008, the stroke death rate fell 34.8%. The actual number of stroke deaths declined 19.4%.

Roger V, Go A, Lloyd-Jones D, Benjamin E, et al. Heart Disease and Stroke Statistics–2012 Update. Circ. 2012; 125(1): e2-e220. http://circ.ahajournals.org/content/125/1/e2

Reference

Title
Heart Disease and Stroke Statistics–2012 Update
Publication
Circ
Publisher
American Heart Association
Publication Date
2012
Authors
Roger V, Go A, Lloyd-Jones D, Benjamin E, et al.
Volume & Issue
Volume 125, Issue 1
Pages
e2-e220
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Every additional dollar spent on antiplatelet therapy versus aspirin for the prevention of stroke in high-risk patients, has produced health gains valued between $2 and $6.  
  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.  
  • Medicines in Development for Heart Disease and Stroke, 2008  
  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.